Retractable Technologies, Inc.

$0.66-2.35%($-0.02)
TickerSpark Score
51/100
Mixed
80
Valuation
20
Profitability
50
Growth
76
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RVP research report →

52-Week Range12% of range
Low $0.60
Current $0.66
High $1.14

Companywww.retractable.com

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.

CEO
Thomas J. Shaw
IPO
2001
Employees
221
HQ
Little Elm, TX, US

Price Chart

-6.61% · this period
$1.06$0.84$0.62May 20Nov 18May 20

Valuation

Market Cap
$19.88M
P/E
-3.16
P/S
0.54
P/B
0.28
EV/EBITDA
-48.14
Div Yield
0.00%

Profitability

Gross Margin
0.20%
Op Margin
-61.02%
Net Margin
-16.93%
ROE
-8.45%
ROIC
-17.76%

Growth & Income

Revenue
$38.27M · 15.78%
Net Income
$-12,565,230 · -5.71%
EPS
$-0.43 · -7.50%
Op Income
$-20,220,815
FCF YoY
41.52%

Performance & Tape

52W High
$1.14
52W Low
$0.60
50D MA
$0.68
200D MA
$0.77
Beta
1.25
Avg Volume
64.22K

Get TickerSpark's AI analysis on RVP

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Nov 14, 25SHAW THOMAS Jbuy5,731
Nov 11, 25SHAW THOMAS Jbuy100
Nov 5, 25SHAW THOMAS Jbuy7,500
Oct 30, 25SHAW THOMAS Jbuy15,000
Oct 28, 25SHAW THOMAS Jbuy35,000
Oct 27, 25SHAW THOMAS Jbuy34,506
Oct 23, 25SHAW THOMAS Jbuy356
Oct 22, 25SHAW THOMAS Jbuy10,000
Oct 14, 25SHAW THOMAS Jbuy14,204
Oct 8, 25SHAW THOMAS Jbuy30,000

Our RVP Coverage

We haven't published any research on RVP yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate RVP Report →

Similar Companies